Does Chemotherapy Work Better in the Afternoon?
Real Health,
Women with lymphoma who received treatment in the afternoon had lower relapse and mortality rates than those treated earlier in…
Sex as a variable
The Lancet,
March 8 will mark International Women's Day. The campaign theme for 2023 will be #EmbraceEquity, with the goal of promoting…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Physician's Weekly,
MONDAY, Feb. 6, 2023 (HealthDay News) — Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Drugs.com,
News Professional By Elana Gotkine HealthDay Reporter MONDAY, Feb. 6, 2023 -- Female patients with diffuse large B-cell…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Arizona Daily Star,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
WFMZ-TV 69,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
The Southern Illinoisan,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Lincoln Journal Star,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Columbus Telegram,
Elana Gotkine MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
The Bismarck Tribune,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Billings Gazette,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Health Day ,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
tdn.com,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Beatrice Daily Sun,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Independent Record,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
St. Louis Post-Dispatch,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
The Sentinel (Pennsylvania),
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Daily Journal,
Elana Gotkine MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Missoulian,
Elana Gotkine MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Northwest Indiana Times,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
The Buffalo News,
Elana Gotkine MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Dispatch-Argus,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Winona Daily News,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Rapid City Journal,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Gazette-Times,
MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when…
AskByGeeks | Afternoon versus morning chemotherapy extends survival in women with lymphoma subtype
AskByGeeks,
February 1, 2023 2 min read source/disclosure Published by: source: Kim DW et al.
News story from EX BULLETIN on Wednesday 01 February 2023
EX BULLETIN,
Chemo in Afternoon Works Better Than in Morning, but Only in Women
Medscape,
Giving chemotherapy in the morning resulted in worse survival and worse toxicity in comparison with giving the same drugs in…
News Radiotherapy Is More Effective in the Afternoon for Female Lymphoma Patients, Study Suggests A new study suggests that female patients with a type of lymphoma respond better to radiotherapy when treated in the afternoon than in the morning.
Technology Networks,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Chemotherapy in the afternoon proved to be effective for female lymphoma patients
Health Reporter,
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: In female lymphoma patients, afternoon treatment decreases mortality rate by 12.5-fold and cancer recurrence by 2.8-fold - News Azi
News Azi,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Afternoon chemotherapy proved to deliver more desirable results for female
ScienMag,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Afternoon chemotherapy proved to deliver more desirable results for female lymphoma patients
Bioengineer.org,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Afternoon chemotherapy proved to deliver more desirable results for female lymphoma patients
EurekAlert!,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Afternoon Chemotherapy Found to Improve Treatment Outcomes in Women With Lymphoma
Pharmacy Times,
Among female patients with lymphoma, afternoon treatment with chemotherapy was found to decrease both mortality rate and cancer…
Afternoon chemotherapy proved to deliver more desirable results for female lymphoma patients
AlphaGalileo,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Non-Hodgkin-Lymphom: Chemotherapie bei Frauen am Nachmittag...
Deutsches Ärzteblatt,
/David A Litman, stock.adobe.com Seoul Patientinnen, die ihre Chemotherapie eines diffusen grozelligen B-Zell-Lymphoms (DLBCL…
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients - ecancer
ecancer,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Chemotherapy schedule affects treatment outcomes in female DLBCL patients
The Medical News,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Female lymphoma patient's afternoon chemotherapy decreases mortality
Newswise,
Newswise — Recently, “chronochemotherapy” have been gaining key interest in the research community.
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study
MedicalXpress,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.
Chemotherapy in the afternoon dramatically improves treatment outcomes in
ScienMag,
Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword.